Drug intelligence / Profile preview

18F-uPA-probe

Development stage
Preclinical
Lead developer
University of Antwerp
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

18F-uPA-probe is a fluorine-18 labeled activity-based positron emission tomography (PET) imaging probe designed for the non-invasive visualization of active urokinase plasminogen activator (uPA) expression in tumors. Developed by researchers at the University of Antwerp, the probe is based on the small-molecule, irreversible, and selective uPA inhibitor UAMC-00150. It consists of a diphenyl phosphonate warhead with a guanidine phenylalanine moiety at the P1 position, connected via a polyethylene glycol (PEG) linker to a [18F]-4-fluorobenzoyl group. The probe covalently and irreversibly binds to the active site of uPA, allowing quantitative PET imaging of uPA activity, which is a key biomarker for cancer invasion and metastasis (particularly in breast cancer).

Other names
18F-labeled uPA inhibitor18F-uPA PET-probe18F-uPA-PET-probe18F-uPA activity-based probe
02

Targets

PLAU (uPA)

Beyond the preview

Go deeper on 18F-uPA-probe.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 18F-uPA-probe.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call